Global Sleep Apnea Devices Market to exceed $ 10 Bn by 2025

February 04, 2020


As per the report ‘Sleep Apnea Devices Market Size By Product (Therapeutics {Airway Clearance System, Adaptive Servo-ventilation {ASV}, Positive Airway Pressure {PAP} Device, Oral Appliances, Oxygen Devices}, Diagnostics [Actigraphy Systems, Polysomnography {PSG} Device, Respiratory Polygraph, Single-channel Screening Devices {Pulse Oximeter}), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa), Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report LLC, the global sleep apnea devices market is anticipated to cross USD 10 billion by the year 2025.
 

Rising prevalence of sleeping disorders around the world is the key factor driving the growth of sleep apnea devices market. Sleep apnea is a short-term sleep disorder wherein breathing is repeatedly interrupted during sleep. If untreated, can lead to long-term disorders such as diabetes and cardiovascular diseases.
 

Technologically advanced sleep apnea devices will play a major role in augmenting the business landscape in the years to come. Moreover, poor sleep cycles due to factors such as alcohol intake is increasing the number of sleeping disorder cases, thereby boosting the demand for sleep apnea devices.
 

On the contrary, the high cost associated with sleep apnea devices and therapeutics coupled with stringent regulations will negatively affect the sleep apnea devices market in the coming years.
 

Based on the product type, airway clearance system segment is estimated to grow with a 6.0% CAGR during the forecast period. The increasing prevalence of sleeping disorders paired with growing consumer awareness about these devices will promote the segmental growth.
 

With respect to diagnostics, polysomnography (PSG) device segment registered a revenue of USD 770.1 million in 2018. The segmental growth can be attributed to the rising demand for superior, efficient, and portable sleep apnea devices.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/467587/
 

Considering the geographical landscape, the U.S. sleep apnea devices market generated a revenue of USD 2 billion in 2018 and is expected to see considerable growth during the study period. Growing availability of sleep treatments coupled with presence of key manufacturers is fueling the regional growth.
 

The industry leaders in sleep apnea devices market are BMC Medical Co. Ltd., Becton Dickinson, Cadwell Laboratories Inc., Compumedics Limited, Braebon Medical Corporation, ImThera Medical Inc., Fisher & Paykel Healthcare, GE Healthcare, Invacare Corporation, Itamar Medical Ltd., Curative Medical Inc., Philips Healthcare and Natus Medical Inc.


Frequently Asked Questions (FAQ) :

Rising prevalence of sleeping disorders around the world is the key factor driving the growth of sleep apnea devices market. Sleep apnea is a short-term sleep disorder wherein breathing is repeatedly interrupted during sleep. If untreated, can lead to long-term disorders such as diabetes and cardiovascular diseases. Technologically advanced sleep apnea devices will play a major role in augmenting the business landscape in the years to come. Moreover, poor sleep cycles due to factors such as alcohol intake is increasing the number of sleeping disorder cases, thereby boosting the demand for sleep apnea devices.
The high cost associated with sleep apnea devices and therapeutics coupled with stringent regulations will negatively affect the sleep apnea devices market in the coming years.
The U.S. sleep apnea devices market generated a revenue of USD 2 billion in 2018 and is expected to see considerable growth during the study period. Growing availability of sleep treatments coupled with presence of key manufacturers is fueling the regional growth.
The competitive hierarchy of sleep apnea devices market includes BMC Medical Co. Ltd., Becton Dickinson, Cadwell Laboratories Inc., Compumedics Limited, Braebon Medical Corporation, ImThera Medical Inc., Fisher & Paykel Healthcare, GE Healthcare, Invacare Corporation, Itamar Medical Ltd., Curative Medical Inc., Philips Healthcare and Natus Medical Inc.